Capital Advisors Ltd’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35K Sell
88
-15
-15% -$6.55K ﹤0.01% 573
2026
Q1
$47K Hold
103
0.01% 510
2025
Q4
$58K Buy
103
+5
+5% +$2.66K 0.01% 465
2025
Q3
$44K Sell
98
-29
-23% -$13.9K 0.01% 499
2025
Q2
$69K Buy
127
+3
+2% +$1.57K 0.01% 414
2025
Q1
$61K Hold
124
0.01% 425
2024
Q4
$65K Hold
124
0.01% 415
2024
Q3
$61K Buy
124
+30
+32% +$14K 0.01% 419
2024
Q2
$42K Sell
94
-2
-2% -$797 0.01% 474
2024
Q1
$38K Buy
96
+9
+10% +$3.4K 0.01% 481
2023
Q4
$29K Hold
87
﹤0.01% 506
2023
Q3
$25K Hold
87
﹤0.01% 514
2023
Q2
$30K Buy
87
+58
+200% +$17.5K ﹤0.01% 501
2023
Q1
$7K Sell
29
-66
-69% -$16.3K ﹤0.01% 617
2022
Q4
$10K Buy
95
+68
+252% +$16.6K ﹤0.01% 561
2022
Q3
$5K Buy
+27
New +$5.8K ﹤0.01% 639
2022
Q1
Sell
-3
Closed -$1K 1060
2021
Q4
$1K Buy
+3
New +$1.03K ﹤0.01% 690

Other funds holding ISRG

Capital Advisors Ltd's ISRG Position: Q2 2026 in Review

Capital Advisors Ltd reduced its Intuitive Surgical (ISRG) stake by 15% in Q2 2026, selling an estimated $6.55K and leaving 88 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #573.

Capital Advisors Ltd first reported a position in ISRG in Q4 2021 and has held it in 17 quarters since. The position peaked at $69K in Q2 2025. 2,244 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Capital Advisors Ltd held 88 shares of Intuitive Surgical worth $35K as of Q2 2026.
  • Capital Advisors Ltd sold 15 Intuitive Surgical shares in Q2 2026, an estimated $6.55K.
  • Intuitive Surgical made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #573 holding.
  • Capital Advisors Ltd first reported a position in Intuitive Surgical in Q4 2021 and has held it in 17 quarters since.
  • Capital Advisors Ltd's Intuitive Surgical position peaked at $69K in Q2 2025.
  • 2,244 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.